Drug
Who makes linagliptin and metformin hydrochloride?
2 companies list linagliptin and metformin hydrochloride as a human prescription drug, including under the names Jentadueto, Jentadueto XR. Forms: tablet, film coated; tablet, film coated, extended release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing linagliptin and metformin hydrochloride
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Boehringer Ingelheim Biopharmaceuticals China LtdGermany | tablet, film coated; tablet, film coated, extended release | NDANDA201281, NDA208026 | 5 | 3 |
| Novadoz Pharmaceuticals LLC | tablet, film coated | ANDAANDA208459 | 3 | 0 |
Enquiry
Common questions
- Who makes linagliptin and metformin hydrochloride?
- 2 companies list linagliptin and metformin hydrochloride as a human prescription drug in the openFDA NDC Directory, led by Boehringer Ingelheim Biopharmaceuticals China Ltd, Novadoz Pharmaceuticals LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic Jentadueto?
- 1 company lists linagliptin and metformin hydrochloride under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.